OBJECTIVES: Over the past decades, Vietnam has made great strides in reducing the rate of mortality in HIV-related deaths, due to increased access of antiretroviral therapy (ART); however, given the significantly high level of treatment failure (TF), it is essential to identify markers that describe the failure of ART in HIV-1 infected children. METHODS: A nested case-control study was conducted with clinical data collected from 101 HIV-infected children [26 TF and 75 treatment success (TS)] at National Hospital of Pediatrics, Vietnam (2008-2012). RESULTS: The results showed that certain factors including height, weight, vaccination with Hepatitis B, and platelet were significantly different between TF and TS before starting the treatment. In addition, age to start the treatment, CD4 percentage, and opportunistic infection were found to significantly predict treatment outcome most frequently, implying the importance of clinical markers in the treatment response by Cox regression analysis. CONCLUSIONS: There is an inherent complexity within clinical markers that is challenging to determine HIV-pediatric failure and further research is needed to build a complete picture to guide clinical, evidence-based practice.
OBJECTIVES: Over the past decades, Vietnam has made great strides in reducing the rate of mortality in HIV-related deaths, due to increased access of antiretroviral therapy (ART); however, given the significantly high level of treatment failure (TF), it is essential to identify markers that describe the failure of ART in HIV-1 infectedchildren. METHODS: A nested case-control study was conducted with clinical data collected from 101 HIV-infectedchildren [26 TF and 75 treatment success (TS)] at National Hospital of Pediatrics, Vietnam (2008-2012). RESULTS: The results showed that certain factors including height, weight, vaccination with Hepatitis B, and platelet were significantly different between TF and TS before starting the treatment. In addition, age to start the treatment, CD4 percentage, and opportunistic infection were found to significantly predict treatment outcome most frequently, implying the importance of clinical markers in the treatment response by Cox regression analysis. CONCLUSIONS: There is an inherent complexity within clinical markers that is challenging to determine HIV-pediatric failure and further research is needed to build a complete picture to guide clinical, evidence-based practice.
Authors: Susan D Emmett; Coleen K Cunningham; Blandina T Mmbaga; Grace D Kinabo; Werner Schimana; Mark E Swai; John A Bartlett; John A Crump; Elizabeth A Reddy Journal: J Acquir Immune Defic Syndr Date: 2010-08 Impact factor: 3.731
Authors: Kudakwashe C Takarinda; Anthony D Harries; Ray W Shiraishi; Tsitsi Mutasa-Apollo; Abu Abdul-Quader; Owen Mugurungi Journal: Int J Infect Dis Date: 2014-11-15 Impact factor: 3.623
Authors: Mariangela Cavarelli; Ingrid Karlsson; Marisa Zanchetta; Liselotte Antonsson; Anna Plebani; Carlo Giaquinto; Eva Maria Fenyö; Anita De Rossi; Gabriella Scarlatti Journal: PLoS One Date: 2008-09-29 Impact factor: 3.240
Authors: Masahiko Mori; Emily Adland; Paolo Paioni; Alice Swordy; Luisa Mori; Leana Laker; Maximilian Muenchhoff; Philippa C Matthews; Gareth Tudor-Williams; Nora Lavandier; Anriette van Zyl; Jacob Hurst; Bruce D Walker; Thumbi Ndung'u; Andrew Prendergast; Philip Goulder; Pieter Jooste Journal: PLoS One Date: 2015-07-07 Impact factor: 3.240
Authors: A Fuchs; N Lübke; L Schmidt; B-E O Jensen; A Walker; V Keitel-Anselmino; V di Cristanziano; M Böhm; E Knops; E Heger; R Kaiser; A de Luca; M Oette; D Häussinger; J Timm Journal: Infection Date: 2021-02-03 Impact factor: 3.553